Julie Sunderland, MBA, is the co-founder of and a managing partner at Biomatics Capital Partners. Before founding Biomatics in 2016, Julie was director of program-related investments for the Bill & Melinda Gates Foundation. In that role, she led the foundation’s $1.5 billion strategic investment pool, funded 50 investments (including 30 in health care), and built a team of ten investment professionals. Julie also chaired the Bill & Melinda Gates Foundation’s investment committee, which reviews all program-related investments. Previously, she advised foundations, development finance institutions, and governments on venture capital, SME financing, and technical assistance programs.
Julie holds a BA from Harvard University, an MBA from Wharton Business School, and an MA from the Johns Hopkins School of Advanced International Studies. She is a member of the board of directors for several of Biomatics’ portfolio companies, including Aledade, BlackThorn, eGenesis, and Verana Health.